2017 Precision Medicine Study

Transcription

1 2017 Precision Medicine Study

2 Enabling better health through information technology.

3 Precision Medicine Study Introduction DNA genetic testing companies such as Ancestry.com and 23andMe are becoming increasingly popular across the consumer market, offering limited but valuable insight into your DNA at a relatively low cost. Consumers can find out where they come from and details about their family history they may not have known before. While the hospital market has begun to leverage genomics, or precision medicine, at the point of care, the approach and processes from a delivery standpoint are significantly more complex than the consumer market. This study is a market snapshot of how U.S. healthcare organizations currently approach and plan to approach precision medicine from an IT perspective. While the interest level and potential expectations of precision medicine are extremely high, developing programs and conducting precision medicine at the point of care requires expertise, funds, and IT sophistication that many organizations currently do not have. That said, the study highlights that many organizations with established programs are looking to expand their offerings into different clinical areas while improving their IT approach with current in-house solutions and dedicated precision medicine platforms. Despite limited plans to conduct precision medicine in the future, the next two years of the adoption and development of precision medicine programs as well as IT solutions and infrastructure to address precision medicine needs will be significant. Nearly 70 percent of organizations with plans to conduct precision medicine intend to do so within the next 12 to 24 months. While many new entrants into the precision market will need to rely upon a smattering of IT solutions and 3rd party research help, advancements in these areas could rapidly change not only the IT landscape and research processes but the overall number of organizations looking to provide these services.

4 Study Demographics Methodological Approach: Web based survey Dates of Data Collection: April 26, 2017 to May 4, 2017 Target Audience(s): Biomedical roles, Medical Directors, Laboratory Directors Number of Respondents: 100 Organization Type SecondaryMethodological Approach: HIMSS Analytics LOGIC Dates of Data Collection: April 30, 2017 Target Audience(s): U.S. Hospitals Number of Respondents: 5,460 Organization Size Integrated delivery network 3% Specialty Hospital 2% Academic Medical Center 10% Other 8% Multi-hospital health system 38% Greater than 500 beds 23% Less than 50 beds 24% beds 19% beds 7% Stand-alone hospital 39% beds 27% N=100 N= HIMSS Analytics

5 Precision Medicine Adoption For the purposes of this study, precision medicine is being defined as an approach for disease treatment and prevention that takes into account individual variability in genes, environment and lifestyle for each person. Is your organization currently conducting precision medicine to provide disease treatment and prevention to patients? Adoption of precision medicine across the studies have gone relatively unchanged from 28.5 percent in 2016 to 26 percent in There continues to be limited adoption across the U.S. hospital market as organizations may not have the necessary funds, technology, or clinical expertise on hand to initiate programs and provide precision medicine at the point of care. However momentum continues to increase around the level of interest in developing this emerging clinical approach and while organizations currently conducting precision medicine expand their current approach across more clinical areas. Yes 26.0% Yes 28.5% Unsure 43.0% 2017 vs vs Unsure 37.2% 2017 vs No 31.0% 2017 N=100; 2016 N= HIMSS Analytics No 34.3%

6 Precision Medicine Adoption Segmentation Further breakdown of the types and sizes of organizations conducting precision medicine reveals the continued effort of larger, research-based organizations such as academic medical centers (AMCs) and organizations with more than 500 beds. Organization Type Bed Size Yes No Unsure Yes No Unsure 100.0% 100.0% 100% 100% 90% 90% 80% 80% 70% 70% 60.5% 60% 60% 71.4% 50% 50% 40% 35.9% 40% 33.3% 33.3% 33.3% 30% 30% 20% 20% 10.5% 28.9% 10% 10% 20.5% 43.6% 21.7% 34.8% 43.5% 28.6% 19.2% 34.6% 46.2% 26.3% 36.8% 36.8% 45.5% 13.6% 40.9% 0% 0% AMC (n=10) IDN (n=3) Multi-Hospital Health System (n=38) Specialty Hospital (n=2) Stand-Alone Hospital (n=39) Less than 50 beds (n=23) 50 to 100 beds (n=7) 101 to 250 beds (n=26) 251 to 500 beds (n=19) Greater than 500 (n=22) N= HIMSS Analytics

7 Precision medicine areas will continue to expand In which of the following areas are you conducting precision medicine? (please select all that apply) Oncology 62.5% 79.5% Cardiology 28.2% 50.0% Nephrology 29.2% Endocrinology 20.8% Most organizations conducting precision medicine continue to focus on oncology as their primary area due to the Prenatal 20.8% 30.8% Precision Medicine Initiative and a large amount of the provided funds going to the National Cancer Institute (NCI) Neurology Epidemiology Other 10.3% 8.3% 10.3% 16.7% 16.7% 38.5% for the development of cancer treatments. However gains have been made in other clinical areas such as cardiology, which showed significant increase from roughly 28 percent in 2016 to 50 percent in Unsure 4.2% 10.3% 0% 10% 20% 30% 40% 50% 60% 70% 80% 2017 N=26; 2016 N= HIMSS Analytics

8 Precision medicine IT approach continues to be mixed Which of the following best describes your IT approach to precision medicine? Unsure 16% Other 8% Uses dedicated precision medicine platform AND in-house solutions 36% From an IT perspective, organizations continue to primarily use a mix of solutions to meet their precision medicine needs. In 2016 roughly 18 percent of respondents with precision medicine initiatives in place used a combination of a dedicated precision medicine solution in conjunction with solutions already established in-house compared to 36 percent in the most recent study. Uses a dedicated precision medicine platform only 16% Uses current in-house solutions only 24% N= HIMSS Analytics The level of uncertainty around precision medicine and IT approach has dropped dramatically from just over 46 percent of respondents in 2016 to 16 percent in The results from this question were not meant to be a snapshot of the entire market. The intention was to show how respondent organizations are approaching precision medicine from an IT perspective, given the newness of incorporating precision medicine at the point of care.

9 Disease diagnosis, innovation leader primary drivers Which of the following best describes your organization s primary driver/incentive to conduct precision medicine? DATA AND INSIGHT AVAILABLE IN PREMIUM ESSENTIALS BRIEF

10 Potential shift in conducting precision medicine Which of the following best describes how your organization is conducting precision medicine? DATA AND INSIGHT AVAILABLE IN PREMIUM ESSENTIALS BRIEF

11 Increase plans for in-house precision medicine processes DATA AND INSIGHT AVAILABLE IN PREMIUM ESSENTIALS BRIEF

12 Integration of clinical & genomic data still an issue What has been the most challenging aspect of integrating clinical and genomic data for the purpose of conducting precision medicine? (please select the top three) DATA AND INSIGHT AVAILABLE IN PREMIUM ESSENTIALS BRIEF

13 Expansion of precision medicine programs expected Does your organization have plans to expand your precision medicine program? In which of the following areas do you plan to expand your precision medicine program and initiatives? (please select all that apply) DATA AND INSIGHT AVAILABLE IN PREMIUM ESSENTIALS BRIEF 2017 HIMSS Analytics

14 Future precision medicine initiatives remain unchanged Does your organization have plans to conduct precision medicine to provide disease treatment and prevention to patients in the future? DATA AND INSIGHT AVAILABLE IN PREMIUM ESSENTIALS BRIEF

15 HIMSS Analytics Toolkit Health IT Actionable Insights LOGIC CapSite Market Insight Trusted Health IT Data The most robust health IT dataset in the world built collaboratively with hospitals. Contracts & Pricing Contracts you need for transparency in pricing and effective go-to-market strategy. Understand Buyer Needs Shift from simply selling a tool to truly identifying and addressing key decision maker needs. Advisory Services Consultative Insight Adoption and Maturity Models to move your organization forward through technology HIMSS Analytics

16 We drive the health IT market in the direction it needs to go EMR Adoption Model Outpatient EMR Adoption Model Analytics Maturity Adoption Model Improved Patient Care and Health IT Insights Continuity of Care Maturity Model 2017 HIMSS Analytics

17 Get all the insights in the Premium Essentials Brief Highlights from the 2017 Precision Medicine Study include: Year over year adoption of precision medicine, including segmentation by organization type and bed size Clinical areas in which precision medicine is being conducted and organizational IT approach Future organizational plans to take sample and sequence analysis in house Primary barriers of adoption for conducting precision medicine Purchase the Study